Where pharma spends, docs prescribe more gabapentin, a potential drug of abuse
Pharmaceutical companies' payments to doctors may be influencing them to prescribe more expensive, brand-name versions of the pain drug gabapentin, a team of researchers report in the July 8 issue of JAMA Internal Medicine, ...
Jul 8, 2019
0
3